Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2019-12-20
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled (2: 1), multicenter clinical phase II
clinical trial evaluating the efficacy and safety of Endostar combined with chemotherapy for
stage IV soft tissue sarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital